![Health in the United States / Center for Science in the Public Interest / Project on Scientific Knowledge and Public Policy / Food and Drug Administration / Pharmaceutical industry / Merrill Goozner / Government Accountability Project / Biogen Idec / Natalizumab / Pharmaceutical sciences / Pharmacology / Clinical research Health in the United States / Center for Science in the Public Interest / Project on Scientific Knowledge and Public Policy / Food and Drug Administration / Pharmaceutical industry / Merrill Goozner / Government Accountability Project / Biogen Idec / Natalizumab / Pharmaceutical sciences / Pharmacology / Clinical research](https://www.pdfsearch.io/img/d75c769ff039d1913a0bd7a40c183c8d.jpg) Date: 2006-03-28 15:03:59Health in the United States Center for Science in the Public Interest Project on Scientific Knowledge and Public Policy Food and Drug Administration Pharmaceutical industry Merrill Goozner Government Accountability Project Biogen Idec Natalizumab Pharmaceutical sciences Pharmacology Clinical research | | Integrity in Science Watch Week of[removed]FDA Puts Five Scientists with Conflicts of Interest On Committee Evaluating Controversial MS Drug Five of the eleven scientists so far selected to judge the safety of the new muAdd to Reading ListSource URL: www.cspinet.orgDownload Document from Source Website File Size: 124,98 KBShare Document on Facebook
|